Mark T. Rogers

4.8k total citations
11 papers, 279 citations indexed

About

Mark T. Rogers is a scholar working on Molecular Biology, Genetics and Cellular and Molecular Neuroscience. According to data from OpenAlex, Mark T. Rogers has authored 11 papers receiving a total of 279 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 4 papers in Genetics and 4 papers in Cellular and Molecular Neuroscience. Recurrent topics in Mark T. Rogers's work include BRCA gene mutations in cancer (4 papers), Muscle Physiology and Disorders (4 papers) and Neurogenetic and Muscular Disorders Research (4 papers). Mark T. Rogers is often cited by papers focused on BRCA gene mutations in cancer (4 papers), Muscle Physiology and Disorders (4 papers) and Neurogenetic and Muscular Disorders Research (4 papers). Mark T. Rogers collaborates with scholars based in United Kingdom, United States and Singapore. Mark T. Rogers's co-authors include Peter S. Harper, Kate Bushby, Patrick F. Chinnery, C. Pollitt, Mary Ann Johnson, David C. Rubinsztein, Andrew Dearlove, Evan Reid, Olivia Osborn and Meena Upadhyaya and has published in prestigious journals such as The American Journal of Human Genetics, Journal of Medical Genetics and Gynecologic Oncology.

In The Last Decade

Mark T. Rogers

11 papers receiving 271 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark T. Rogers United Kingdom 9 153 143 64 57 54 11 279
Matthew Wicklund United States 12 223 1.5× 127 0.9× 74 1.2× 111 1.9× 83 1.5× 34 412
Michiel R. Fokkens Netherlands 9 206 1.3× 176 1.2× 30 0.5× 64 1.1× 36 0.7× 11 312
Satu Sandell Finland 10 232 1.5× 89 0.6× 114 1.8× 46 0.8× 56 1.0× 21 313
Amy Harper United States 8 109 0.7× 99 0.7× 17 0.3× 57 1.0× 36 0.7× 19 281
Manu Jokela Finland 12 236 1.5× 83 0.6× 51 0.8× 114 2.0× 119 2.2× 35 356
Celedonio Márquez Spain 6 83 0.5× 126 0.9× 95 1.5× 16 0.3× 30 0.6× 8 265
C. Fallet France 10 145 0.9× 96 0.7× 36 0.6× 12 0.2× 32 0.6× 15 444
Alberto A. Zambon Italy 11 226 1.5× 61 0.4× 60 0.9× 28 0.5× 44 0.8× 26 324
Meyke Schouten Netherlands 10 221 1.4× 124 0.9× 82 1.3× 60 1.1× 33 0.6× 19 420
Rosanna Trovato Italy 6 146 1.0× 79 0.6× 43 0.7× 20 0.4× 33 0.6× 20 201

Countries citing papers authored by Mark T. Rogers

Since Specialization
Citations

This map shows the geographic impact of Mark T. Rogers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark T. Rogers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark T. Rogers more than expected).

Fields of papers citing papers by Mark T. Rogers

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark T. Rogers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark T. Rogers. The network helps show where Mark T. Rogers may publish in the future.

Co-authorship network of co-authors of Mark T. Rogers

This figure shows the co-authorship network connecting the top 25 collaborators of Mark T. Rogers. A scholar is included among the top collaborators of Mark T. Rogers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark T. Rogers. Mark T. Rogers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Mort, Matthew, et al.. (2014). Identification of two novel SMCHD1 sequence variants in families with FSHD-like muscular dystrophy. European Journal of Human Genetics. 23(1). 67–71. 17 indexed citations
2.
Witt, Jana, Glyn Elwyn, Fiona Wood, et al.. (2014). Adapting the coping in deliberation (CODE) framework: A multi-method approach in the context of familial ovarian cancer risk management. Patient Education and Counseling. 97(2). 200–210. 6 indexed citations
3.
Brain, Kate, Kate Lifford, Lindsay Fraser, et al.. (2012). Psychological outcomes of familial ovarian cancer screening: No evidence of long-term harm. Gynecologic Oncology. 127(3). 556–563. 15 indexed citations
4.
Lifford, Kate, Lindsay Fraser, Adam N. Rosenthal, et al.. (2011). Withdrawal from familial ovarian cancer screening for surgery: Findings from a psychological evaluation study (PsyFOCS). Gynecologic Oncology. 124(1). 158–163. 12 indexed citations
5.
Rieck, G, Kevin Boon Leong Lim, Mark T. Rogers, et al.. (2006). Screening for familial ovarian cancer-management and outcome of women with moderate to high risk of developing ovarian cancer. International Journal of Gynecological Cancer. 16(S1). 86–91. 1 indexed citations
6.
Vinereanu, Dragoş, et al.. (2004). Subclinical cardiac involvement in myotonic dystrophy manifesting as decreased myocardial Doppler velocities. Neuromuscular Disorders. 14(3). 188–194. 28 indexed citations
7.
Rogers, Mark T., Fei Zhao, Peter S. Harper, & Dafydd Stephens. (2002). Absence of hearing impairment in adult onset facioscapulohumeral muscular dystrophy. Neuromuscular Disorders. 12(4). 358–365. 18 indexed citations
8.
Reid, Evan, Andrew Dearlove, Olivia Osborn, Mark T. Rogers, & David C. Rubinsztein. (2000). A Locus for Autosomal Dominant “Pure” Hereditary Spastic Paraplegia Maps to Chromosome 19q13. The American Journal of Human Genetics. 66(2). 728–732. 52 indexed citations
9.
Bushby, Kate, C. Pollitt, Mary Ann Johnson, Mark T. Rogers, & Patrick F. Chinnery. (1998). Muscle pain as a prominent feature of facioscapulohumeral muscular dystrophy (FSHD): four illustrative case reports. Neuromuscular Disorders. 8(8). 574–579. 55 indexed citations
10.
Phillips, Margaret, Mark T. Rogers, Rebecca A. Barnetson, et al.. (1998). PROMM: the expanding phenotype. A family with proximal myopathy, myotonia and deafness. Neuromuscular Disorders. 8(7). 439–446. 24 indexed citations
11.
Upadhyaya, Meena, J. Maynard, Mark T. Rogers, et al.. (1997). Improved molecular diagnosis of facioscapulohumeral muscular dystrophy (FSHD): validation of the differential double digestion for FSHD.. Journal of Medical Genetics. 34(6). 476–479. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026